ArticleHaematologica2020
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis.
Georg Greiner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it